Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Neuromuscular
How could you utilize neuromuscular ultrasound as a marker of disease progression/treatment response in CIDP?
Related Questions
When do you recommend scrambler therapy for chronic neuropathic pain?
How does one interpret an SPEP showing potentially obscured but non-quantifiable M-spike however an IFE showing monoclonal protein?
How frequently do you re-evaluate AChR and MuSK antibodies in patients with clinical and electrodiagnostic evidence of seronegative myasthenia gravis?
Would you recommend muscle or nerve biopsy in a patient with amyoplasia congenita?
What types of cardiac conduction abnormalities would lead you to avoid using tricyclic antidepressants?
How do you use serum IgG levels when treating with FcRN inhibitors?
How do you decide when to add steroid-sparing immunotherapy for myasthenia gravis after starting prednisone and Mestinon?
What is your approach to a child with toe walking with a reassuring exam but a family history of difficulty walking?
How do you counsel patients with dermatomyositis on sun protection?
How do you adjust dosing of rozanolixizumb for MG patients who deteriorate before the minimum re-dosing period?
